JP2002363097A5 - - Google Patents

Download PDF

Info

Publication number
JP2002363097A5
JP2002363097A5 JP2001312701A JP2001312701A JP2002363097A5 JP 2002363097 A5 JP2002363097 A5 JP 2002363097A5 JP 2001312701 A JP2001312701 A JP 2001312701A JP 2001312701 A JP2001312701 A JP 2001312701A JP 2002363097 A5 JP2002363097 A5 JP 2002363097A5
Authority
JP
Japan
Prior art keywords
composition according
composition
pharmaceutically acceptable
stabilizer
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001312701A
Other languages
English (en)
Japanese (ja)
Other versions
JP4691866B2 (ja
JP2002363097A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2001312701A priority Critical patent/JP4691866B2/ja
Priority claimed from JP2001312701A external-priority patent/JP4691866B2/ja
Publication of JP2002363097A publication Critical patent/JP2002363097A/ja
Publication of JP2002363097A5 publication Critical patent/JP2002363097A5/ja
Application granted granted Critical
Publication of JP4691866B2 publication Critical patent/JP4691866B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2001312701A 1999-07-01 2001-10-10 安定化された凍結乾燥型医薬組成物 Expired - Lifetime JP4691866B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001312701A JP4691866B2 (ja) 1999-07-01 2001-10-10 安定化された凍結乾燥型医薬組成物

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP18771399 1999-07-01
JP11-187713 1999-07-01
JP1999187713 1999-07-01
JP2001312701A JP4691866B2 (ja) 1999-07-01 2001-10-10 安定化された凍結乾燥型医薬組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2001507492A Division JP3381722B2 (ja) 1999-07-01 2000-06-29 安定化された凍結乾燥型医薬組成物

Publications (3)

Publication Number Publication Date
JP2002363097A JP2002363097A (ja) 2002-12-18
JP2002363097A5 true JP2002363097A5 (https=) 2007-06-14
JP4691866B2 JP4691866B2 (ja) 2011-06-01

Family

ID=16210881

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001507492A Expired - Lifetime JP3381722B2 (ja) 1999-07-01 2000-06-29 安定化された凍結乾燥型医薬組成物
JP2001312701A Expired - Lifetime JP4691866B2 (ja) 1999-07-01 2001-10-10 安定化された凍結乾燥型医薬組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2001507492A Expired - Lifetime JP3381722B2 (ja) 1999-07-01 2000-06-29 安定化された凍結乾燥型医薬組成物

Country Status (28)

Country Link
US (2) US6774104B1 (https=)
EP (1) EP1107777B1 (https=)
JP (2) JP3381722B2 (https=)
KR (1) KR100454784B1 (https=)
CN (2) CN1179748C (https=)
AR (1) AR024634A1 (https=)
AT (1) ATE280583T1 (https=)
AU (1) AU752265B2 (https=)
BR (2) BR0006823A (https=)
CA (1) CA2341568C (https=)
CZ (1) CZ295720B6 (https=)
DE (1) DE60015279T2 (https=)
ES (1) ES2225161T3 (https=)
HK (1) HK1040057B (https=)
HU (1) HU229089B1 (https=)
ID (1) ID29468A (https=)
IL (2) IL141455A0 (https=)
MX (1) MXPA01000601A (https=)
NO (1) NO330353B1 (https=)
NZ (1) NZ510290A (https=)
OA (1) OA11601A (https=)
PL (1) PL200141B1 (https=)
PT (1) PT1107777E (https=)
RU (1) RU2251411C2 (https=)
TR (1) TR200100609T1 (https=)
TW (1) TWI233805B (https=)
WO (1) WO2001002002A1 (https=)
ZA (1) ZA200101589B (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
ITMI20021040A1 (it) * 2002-05-16 2003-11-17 Novuspharma Spa Composizioni farmaceutiche iniettabili di un derivato antracenedionico ad attivita' antitumorale
ATE528003T1 (de) 2002-07-31 2011-10-15 Senju Pharma Co Wässrige, flüssigkeitszubereitungen und lichtstabilisierte wässrige flüssigkeitszubereitungen
US8877168B1 (en) 2002-07-31 2014-11-04 Senju Pharmaceuticals Co., Ltd. Aqueous liquid preparations and light-stabilized aqueous liquid preparations
US7119061B2 (en) * 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
US20060074014A1 (en) * 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
AU2003299561A1 (en) * 2002-11-18 2004-06-15 Vicuron Pharmaceuticals Inc. Compositions and methods for treating bacterial infections with protein-dalbavancin complexes
US7612066B2 (en) 2004-03-04 2009-11-03 Eisai R&D Management Co., Ltd. Composition containing benzamidine derivative and method for stabilizing benzamidine derivative
JP2007538046A (ja) * 2004-05-19 2007-12-27 ノイロサーチ アクティーゼルスカブ 新規なアザビシクロアリール誘導体
WO2006053383A1 (en) * 2004-11-22 2006-05-26 Anadis Ltd Bioactive compositions
KR101307999B1 (ko) 2004-12-01 2013-09-12 니폰 조키 세야쿠 가부시키가이샤 건조물 및 그 제조방법
WO2007010995A1 (ja) * 2005-07-20 2007-01-25 Kyowa Medex Co., Ltd. 生体試料中のペプチドの安定化方法
CN1962852B (zh) * 2006-11-27 2011-11-09 西北农林科技大学 红景天多糖在制备抗冻剂中的新用途及其产品和制备方法
CN102614492B (zh) * 2011-01-31 2013-12-11 上海天伟生物制药有限公司 一种含有棘白菌素类抗真菌剂米卡芬净的液体药用组合物
CN102614491B (zh) * 2011-01-31 2014-04-16 上海天伟生物制药有限公司 一种含有棘白菌素类抗真菌剂米卡芬净的药用组合物及其制备方法和用途
NZ702063A (en) * 2012-05-22 2016-11-25 Paion Uk Ltd Compositions comprising short-acting benzodiazepines
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US9320740B2 (en) 2013-03-15 2016-04-26 Merck Sharp & Dohme Corp. Ceftolozane-tazobactam pharmaceutical compositions
CN110279698B (zh) 2013-03-15 2022-10-28 默沙东有限责任公司 头孢特咯瓒抗生素组合物
CN103330933B (zh) * 2013-04-26 2015-08-05 江苏豪森药业股份有限公司 含有米卡芬净或其盐的药物组合物
CN103330932B (zh) * 2013-04-26 2015-12-23 江苏豪森药业股份有限公司 一种米卡芬净或其盐的药物组合物
ES2978920T3 (es) * 2013-06-05 2024-09-23 Univ British Columbia Compuestos antifibrogénicos, métodos y usos de los mismos
EP3043797B1 (en) 2013-09-09 2020-04-08 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
KR101611349B1 (ko) 2014-04-14 2016-04-12 신우철 안정성이 개선된 밀크씨슬 엑스의 제형
EP3150621A4 (en) * 2014-05-29 2017-12-27 Shanghai Techwell Biopharmaceutical Co., Ltd Composition of cyclic peptide compound, preparation method for same, and uses thereof
MY190283A (en) * 2014-12-05 2022-04-12 Meiji Seika Pharma Co Ltd Method for producing crystals of diazabicyclooctane derivative and stable lyophilized preparation
ES2777942T3 (es) * 2014-12-31 2022-04-22 Galenicum Health S L U Composiciones farmacéuticas estables que comprenden micafungina
PL3058958T3 (pl) 2015-02-23 2019-02-28 Selectchemie Ag Kompozycja anidulafunginy
WO2018112330A1 (en) 2016-12-16 2018-06-21 Baxter International Inc. Micafungin compositions
US11185527B2 (en) 2017-06-26 2021-11-30 Wayne State University Methods and compositions relating to steroid hormone receptor-dependent cancers
RU2666148C1 (ru) * 2017-10-05 2018-09-06 Общество с ограниченной ответственностью "Новые Антибиотики" Способ получения водорастворимой лиофилизированной формы соли бис(2-тио-4,6-диоксо-1,2,3,4,5,6-гексагидропиримидин-5-ил)-(4-нитрофенил)метана
EP3485873A1 (en) 2017-11-17 2019-05-22 Cadila Healthcare Limited Stable pharmaceutical injectable compositions of micafungin

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03193735A (ja) 1989-12-22 1991-08-23 Shionogi & Co Ltd グリコペプチド系抗生物質の安定化組成物
JPH03240727A (ja) 1990-02-15 1991-10-28 Toyo Jozo Co Ltd ニューモシスチス・カリニ肺炎治療剤
IL98506A (en) * 1990-06-18 1996-09-12 Fujisawa Pharmaceutical Co Cyclic peptide antibiotics processes for the preparation thereof and pharmaceutical compositions containing them
JP3193735B2 (ja) 1991-07-24 2001-07-30 株式会社リコー カラー画像形成装置の搬送装置
RU2095081C1 (ru) * 1991-12-13 1997-11-10 Акционерное общество "Биофа" Фармацевтическая композиция антивирусного действия
JPH0651641A (ja) 1992-07-30 1994-02-25 Olympus Optical Co Ltd 湿式現像装置
JPH06172204A (ja) * 1992-12-09 1994-06-21 Asahi Chem Ind Co Ltd アクレアシン類含有リポソーム製剤およびその製造法
JP3240727B2 (ja) 1993-02-25 2001-12-25 ソニー株式会社 偏平型陰極線管の画像歪補正装置
US6268338B1 (en) * 1993-04-30 2001-07-31 Merck & Co., Inc. Cyclohexapeptidyl amine compounds
IL109615A (en) * 1993-05-17 2000-12-06 Fujisawa Pharmaceutical Co Cyclic polypeptide derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
RU2165423C2 (ru) * 1994-10-07 2001-04-20 Фудзисава Фармасьютикал Ко., Лтд. Полипептидное соединение, способ его получения и фармацевтическая композиция
GB9512854D0 (en) * 1995-06-23 1995-08-23 Wellcome Found Novel formulation
US6245349B1 (en) * 1996-02-23 2001-06-12 éLAN CORPORATION PLC Drug delivery compositions suitable for intravenous injection
JP3123078B2 (ja) * 1996-03-08 2001-01-09 藤沢薬品工業株式会社 環状リポペプチド物質の脱アシル化法
PE63998A1 (es) * 1996-04-19 1998-10-30 Merck & Co Inc Composiciones anti-fungosas
JPH09301997A (ja) 1996-05-17 1997-11-25 Yamanouchi Pharmaceut Co Ltd 新規環状ペプチド系化合物
AUPO371596A0 (en) * 1996-11-19 1996-12-12 Fujisawa Pharmaceutical Co., Ltd. New compound
FR2755857B1 (fr) * 1996-11-19 1998-12-24 Rhone Poulenc Rorer Sa Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation
AUPO381496A0 (en) * 1996-11-25 1996-12-19 Fujisawa Pharmaceutical Co., Ltd. New compound
JPH10279498A (ja) * 1997-04-07 1998-10-20 Nippon Shinyaku Co Ltd 慢性関節リウマチ治療剤
JP3544847B2 (ja) * 1998-01-16 2004-07-21 三菱電機株式会社 光学的情報再生方法および装置
HK1040062A1 (zh) * 1999-03-03 2002-05-24 Eli Lilly And Company 含有成胶束表面活性剂的棘白菌素药物配方
HK1040369A1 (zh) * 1999-03-03 2002-06-07 Eli Lilly And Company 制备药物口服ecb配方和组合物的方法
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent

Similar Documents

Publication Publication Date Title
JP2002363097A5 (https=)
RU2001108569A (ru) Стабилизированная фармацевтическая композиция в лиофилизированной форме
JP3623962B2 (ja) ヒドロキソコバラミンの鼻中投与用医薬組成物
CA2341568A1 (en) Stabilized pharmaceutical composition in lyophilized form
CA2288143A1 (en) Activated protein c formulations
JP2003506416A5 (https=)
JP2006516648A5 (https=)
JP2004509061A5 (https=)
JP2004504406A5 (https=)
JPWO2019107530A1 (ja) 炎症性腸疾患の治療薬
JP2003532640A5 (https=)
KR100546450B1 (ko) 약학 조성물
RU2002100058A (ru) Кристаллические производные 1-метилкарбапенема
KR20220081311A (ko) 니클로사마이드를 포함하는 근육내 및/또는 피하 투여용 약학적 조성물
JP2002509154A5 (https=)
JP4752987B2 (ja) 外用剤組成物
JP2002080490A (ja) 新規ヌクレオシド
US5925625A (en) Pharmaceutical composition for the intranasal administration of hydroxocobalamin
JP2001322936A (ja) 眼科用組成物
US10308937B2 (en) Combination long acting compositions and methods for Hepatitis C
US20170333460A1 (en) Long acting pharmaceutical compositions for hepatitis c
WO2003026570A3 (en) Reduced toxicity cisplatin formulations and methods for using the same
JP5514270B2 (ja) アシタザノラスト含有組成物
JPH0678241B2 (ja) ｔＰＡ医薬組成物
JP2007106754A (ja) アシタザノラスト含有組成物